Tower Research Capital (TRC)’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDS
HPC
SVWAG
CIA
Tower Research Capital (TRC)'s IBDS Position: Q2 2026 in Review
Tower Research Capital (TRC) sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2026, closing a stake of 92 shares — an estimated $2.23K sold.
Tower Research Capital (TRC) first reported a position in IBDS in Q2 2023 and held it in 10 quarters. The position peaked at $191K in Q2 2025. 415 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.
- Tower Research Capital (TRC) reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 92 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $2.23K.
- Tower Research Capital (TRC) first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2023 and held it in 10 quarters.
- Tower Research Capital (TRC)'s iShares iBonds Dec 2027 Term Corporate ETF position peaked at $191K in Q2 2025.
- 415 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.